Pediatric Targeted Therapy 2.0 - PTT2.0
The “Pediatric Targeted Therapy” program aims at the identification of drugable molecular targets in tumors in single cases. Most tumor cells harbour more than one tumor-propagating change, therefore a strategy employing several targeted therapies seems appropriate as well as very promising.
We analyze formalin fixed parafin embedded (FFPE) tumor material and blood for druggable alterations.
If you are interested, please contact Dr. Jonas Ecker (via This email address is being protected from spambots. You need JavaScript enabled to view it.).
 

Please always obtain written consent for PTT2.0 (see links below) and send a copy with the analysis request. Please notice that referring institutes from outside of Germany have to cover the costs for PTT2.0 analyses, since our funding only covers patients treated in Germany at this stage. Please inquire if you wish to be informed about the costs.

Please also consider the shipment SOP.